The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study.

Autor: Kutlu Ö; Department of Dermatology and Venereology, School of Medicine, Tokat Gaziosmanpaşa University, Tokat, Turkey., Demircan YT; Department of Dermatology and Venereology, Adana Seyhan State Hospital, Adana, Turkey., Yıldız K; Department of Dermatology and Venereology, Adana Seyhan State Hospital, Adana, Turkey., Kalkan G; Department of Dermatology and Venereology, School of Medicine, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Demirseren DD; Department of Dermatology and Venereology, School of Medicine, Ankara Bilkent City Hospital, University of Health Science, Ankara, Turkey., An İ; Department of Dermatology and Venereology, Şanlıurfa Training and Research Hospital, Şanlıurfa, Turkey., Oba MÇ; Department of Dermatology and Venereology, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Istanbul, Turkey., Emre S; Department of Dermatology and Venereology, School of Medicine, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Şenel E; Department of Dermatology and Venereology, School of Medicine, Erol Olcak Training and Research Hospital, Hitit Üniversity, Çankırı, Turkey., Bilgili SG; Department of Dermatology and Venereology, School of Medicine, Van Yüzüncü Yıl University, Van, Turkey., Savaş SE; Department of Dermatology and Venereology, School of Medicine, Sultan 2. Abdülhamid Han Training and Research Hospital, Health Science University, Istanbul, Turkey., Aktürk AŞ; Department of Dermatology and Venereology, School of Medicine, Kocaeli University, Kocaeli, Turkey., Türkmen D; Department of Dermatology and Venereology, School of Medicine, İnönü University, Malatya, Turkey., Çakmak SK; Department of Dermatology and Venereology, School of Medicine, Ankara Bilkent City Hospital, University of Health Science, Ankara, Turkey., Kulaklı S; Department of Dermatology and Venereology, School of Medicine, Giresun University, Kocaeli, Turkey., Demirbaş A; Department of Dermatology and Venereology, School of Medicine, Evliya Çelebi Training and Research Hospital, Kütahya Health Science University, Konya, Turkey., Altunışık N; Department of Dermatology and Venereology, School of Medicine, İnönü University, Malatya, Turkey., Coşansu NC; Department of Dermatology and Venereology, Sakarya Training and Research Hospital, Sakarya, Turkey., Aksoy GG; Department of Dermatology and Venereology, School of Medicine, Ankara Bilkent City Hospital, University of Health Science, Ankara, Turkey., Tosun M; Department of Dermatology and Venereology, School of Medicine, Sivas Cumhuriyet University, Sivas, Turkey., Kurt BÖ; Department of Dermatology and Venereology, Adıyaman Training and Research Hospital, Antalya, Turkey., Şentürk N; Department of Dermatology and Venereology, School of Medicine, Samsun Ondokuz Mayıs University, Samsun, Turkey., Şener S; Department of Dermatology and Venereology, School of Medicine, İnönü University, Malatya, Turkey., Özden HK; Department of Dermatology and Venereology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey., Temiz SA; Department of Dermatology and Venereology, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey., Atak MF; Department of Dermatology and Venereology, Tokat State Hospital, Tokat, Turkey., Süslü H; Department of Dermatology and Venereology, ıstanbul Haseki Training and Research Hospital, Istanbul, Turkey., Oğuz ID; Department of Dermatology and Venereology, School of Medicine, Giresun University, Kocaeli, Turkey., Kılıç S; Department of Dermatology and Venereology, School of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey., Ustaoğlu E; Department of Dermatology and Venereology, Bursa City Hospital, Bursa, Turkey., Topal İO; Department of Dermatology and Venereology, Prof. Dr. Cemil Tascioglu City Hospital, Health Science University, Istanbul, Turkey., Akbulut TÖ; Department of Dermatology and Venereology, ıstanbul Haseki Training and Research Hospital, Istanbul, Turkey., Korkmaz İ; Department of Dermatology and Venereology, ıstanbul Haseki Training and Research Hospital, Istanbul, Turkey., Kılıç A; Department of Dermatology and Venereology, School of Medicine, Balıkesir University, Balıkesir, Turkey., Hızlı P; Department of Dermatology and Venereology, School of Medicine, Balıkesir University, Balıkesir, Turkey., Küçük ÖS; Department of Dermatology and Venereology, School of Medicine, Bezmialem Vakıf University, Istanbul, Turkey., Çaytemel C; Department of Dermatology and Venereology, School of Medicine, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey., Kara RÖ; Department of Dermatology and Venereology, Sakarya Training and Research Hospital, Sakarya, Turkey., Koska MC; Department of Dermatology and Venereology, Artvin State Hospital, Artvin, Turkey., Tatar K; Department of Dermatology and Venereology, School of Medicine, Van Yüzüncü Yıl University, Van, Turkey., Dikicier BS; Department of Dermatology and Venereology, School of Medicine, Sakarya Training and Research Hospital, Sakarya University, Sakarya, Turkey., Ağırgöl Ş; Department of Dermatology and Venereology, School of Medicine, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey., Akşan B; Department of Dermatology and Venereology, School of Medicine, Giresun University, Kocaeli, Turkey., Karadağ AS; Memorial Health Group, Atasehir and Sisli Hospital, Dermatology Clinic, Istanbul, Turkey.

Publikováno v: International journal of dermatology [Int J Dermatol] 2023 Feb; Vol. 62 (2), pp. 202-211. Date of Electronic Publication: 2022 Oct 25.

New markers to predict the response to omalizumab in chronic spontaneous urticaria.

Autor: Coşansu NC; Department of Dermatology, Education and Research Hospital, Sakarya University, Sakarya, Turkey., Kara RÖ; Department of Dermatology, Education and Research Hospital, Sakarya University, Sakarya, Turkey., Yaldiz M; Department of Dermatology, Education and Research Hospital, Sakarya University, Sakarya, Turkey., Dikicier BS; Department of Dermatology, Education and Research Hospital, Sakarya University, Sakarya, Turkey.

Publikováno v: Dermatologic therapy [Dermatol Ther] 2022 Aug; Vol. 35 (8), pp. e15589. Date of Electronic Publication: 2022 Jun 08.

HALP score for chronic spontaneous urticaria: Does it differ from healthy subjects?

Autor: ERDAL, Hüseyin¹ herdalyfa@gmail.com, GÜNAYDIN, Fatma Esra²

Publikováno v: Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi. Dec2023, Vol. 40 Issue 4, p677-680. 4p.

Predictive value of the systemic immune inflammation index and systemic inflammatory response index on omalizumab drug survival in chronic spontaneous urticaria.

Autor: Fabi, Adriano, Milosavljevic, Stefan, Lang, Claudia C. V., Guillet, Carole, Schmid-Grendelmeier, Peter

Publikováno v: Allergo Journal International; Feb2024, Vol. 33 Issue 1, p32-40, 9p

Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study.

Autor: Pierrard G; CHU Lille, University Lille, Service de Dermatologie, Lille, France., Bernier C; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Nantes, Service de Dermatologie, Nantes, France., Du-Thanh A; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Montpellier, Service de Dermatologie, Montpellier, France., Bara C; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Le Mans, Service de Dermatologie, Le Mans, France., Soria A; French Chronic Urticaria Study Group (GUS), Paris, France.; Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris, France., Castelain F; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Besançon, Service de Dermatologie, Besançon, France., Boccon-Gibod I; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Grenoble, Service de Médecine Interne et Immunologie Clinique, Centre de Reference des Angiœdèmes, Grenoble, France., Hacard F; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Lyon, Service Allergologie et Immunologie Clinique, Lyon, France., Delaunay J; French Chronic Urticaria Study Group (GUS), Paris, France.; CHU Angers, Service de Dermatologie Angers, Angers, France., de Montjoye L; French Chronic Urticaria Study Group (GUS), Paris, France.; Department of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Staumont-Salle D; CHU Lille, University Lille, Service de Dermatologie, Lille, France.; French Chronic Urticaria Study Group (GUS), Paris, France.; U1286 Inserm INFINITE Institute for Translational Research in Inflammation, Lille, France., Dezoteux F; CHU Lille, University Lille, Service de Dermatologie, Lille, France.; French Chronic Urticaria Study Group (GUS), Paris, France.; U1286 Inserm INFINITE Institute for Translational Research in Inflammation, Lille, France.

Publikováno v: Allergy [Allergy] 2024 Sep; Vol. 79 (9), pp. 2448-2457. Date of Electronic Publication: 2024 Jul 26.